nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.0652	0.0918	CbGbCtD
Theophylline—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0255	0.0359	CbGbCtD
Theophylline—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0251	0.0354	CbGbCtD
Theophylline—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0251	0.0354	CbGbCtD
Theophylline—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0229	0.0322	CbGbCtD
Theophylline—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0215	0.0303	CbGbCtD
Theophylline—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0215	0.0303	CbGbCtD
Theophylline—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0206	0.029	CbGbCtD
Theophylline—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0194	0.0274	CbGbCtD
Theophylline—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0194	0.0273	CbGbCtD
Theophylline—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0194	0.0273	CbGbCtD
Theophylline—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.019	0.0268	CbGbCtD
Theophylline—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.019	0.0268	CbGbCtD
Theophylline—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0188	0.0265	CbGbCtD
Theophylline—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0182	0.0257	CbGbCtD
Theophylline—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0177	0.0249	CbGbCtD
Theophylline—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0177	0.0249	CbGbCtD
Theophylline—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0175	0.0247	CbGbCtD
Theophylline—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0175	0.0247	CbGbCtD
Theophylline—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0163	0.0229	CbGbCtD
Theophylline—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.016	0.0226	CbGbCtD
Theophylline—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.016	0.0226	CbGbCtD
Theophylline—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0151	0.0213	CbGbCtD
Theophylline—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0147	0.0208	CbGbCtD
Theophylline—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0147	0.0207	CbGbCtD
Theophylline—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0138	0.0195	CbGbCtD
Theophylline—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0134	0.0189	CbGbCtD
Theophylline—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0133	0.0187	CbGbCtD
Theophylline—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0133	0.0187	CbGbCtD
Theophylline—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0127	0.0179	CbGbCtD
Theophylline—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0121	0.0171	CbGbCtD
Theophylline—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0121	0.0171	CbGbCtD
Theophylline—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.012	0.0169	CbGbCtD
Theophylline—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0113	0.0159	CbGbCtD
Theophylline—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0113	0.0159	CbGbCtD
Theophylline—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0102	0.0143	CbGbCtD
Theophylline—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0102	0.0143	CbGbCtD
Theophylline—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00879	0.0124	CbGbCtD
Theophylline—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00853	0.012	CbGbCtD
Theophylline—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00771	0.0109	CbGbCtD
Theophylline—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00771	0.0109	CbGbCtD
Theophylline—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0074	0.0104	CbGbCtD
Theophylline—ADORA1—nerve—acquired immunodeficiency syndrome	0.00274	0.0317	CbGeAlD
Theophylline—PDE5A—endothelium—acquired immunodeficiency syndrome	0.00246	0.0285	CbGeAlD
Theophylline—PDE5A—blood plasma—acquired immunodeficiency syndrome	0.00219	0.0253	CbGeAlD
Theophylline—PDE3A—blood plasma—acquired immunodeficiency syndrome	0.00213	0.0246	CbGeAlD
Theophylline—PDE3B—blood—acquired immunodeficiency syndrome	0.00128	0.0148	CbGeAlD
Theophylline—PDE3B—bone marrow—acquired immunodeficiency syndrome	0.00123	0.0143	CbGeAlD
Theophylline—PDE5A—retina—acquired immunodeficiency syndrome	0.0012	0.0138	CbGeAlD
Theophylline—HDAC2—retina—acquired immunodeficiency syndrome	0.00112	0.013	CbGeAlD
Theophylline—PDE3B—lung—acquired immunodeficiency syndrome	0.00112	0.0129	CbGeAlD
Theophylline—ADORA2B—blood—acquired immunodeficiency syndrome	0.00106	0.0122	CbGeAlD
Theophylline—ADA—lymphoid tissue—acquired immunodeficiency syndrome	0.00103	0.0119	CbGeAlD
Theophylline—ADA—digestive system—acquired immunodeficiency syndrome	0.00101	0.0117	CbGeAlD
Theophylline—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00101	0.0116	CbGeAlD
Theophylline—HDAC2—skin of body—acquired immunodeficiency syndrome	0.000984	0.0114	CbGeAlD
Theophylline—PDE4C—nervous system—acquired immunodeficiency syndrome	0.000982	0.0114	CbGeAlD
Theophylline—ADORA2B—vagina—acquired immunodeficiency syndrome	0.00098	0.0113	CbGeAlD
Theophylline—ADA—blood—acquired immunodeficiency syndrome	0.000967	0.0112	CbGeAlD
Theophylline—PDE4C—central nervous system—acquired immunodeficiency syndrome	0.000945	0.0109	CbGeAlD
Theophylline—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000942	0.0109	CbGeAlD
Theophylline—ADA—bone marrow—acquired immunodeficiency syndrome	0.000936	0.0108	CbGeAlD
Theophylline—ADORA2A—lymphoid tissue—acquired immunodeficiency syndrome	0.000935	0.0108	CbGeAlD
Theophylline—PDE4D—lung—acquired immunodeficiency syndrome	0.000933	0.0108	CbGeAlD
Theophylline—ADORA2B—lung—acquired immunodeficiency syndrome	0.000927	0.0107	CbGeAlD
Theophylline—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.000915	0.0106	CbGeAlD
Theophylline—ADA—vagina—acquired immunodeficiency syndrome	0.000896	0.0104	CbGeAlD
Theophylline—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000894	0.0103	CbGeAlD
Theophylline—ADORA2A—blood—acquired immunodeficiency syndrome	0.00088	0.0102	CbGeAlD
Theophylline—ADORA2B—nervous system—acquired immunodeficiency syndrome	0.000858	0.00992	CbGeAlD
Theophylline—ADA—lung—acquired immunodeficiency syndrome	0.000848	0.0098	CbGeAlD
Theophylline—ADORA2A—spinal cord—acquired immunodeficiency syndrome	0.000847	0.0098	CbGeAlD
Theophylline—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000847	0.0098	CbGeAlD
Theophylline—PDE5A—digestive system—acquired immunodeficiency syndrome	0.000841	0.00972	CbGeAlD
Theophylline—ADORA2B—central nervous system—acquired immunodeficiency syndrome	0.000826	0.00955	CbGeAlD
Theophylline—PDE4A—lung—acquired immunodeficiency syndrome	0.000826	0.00955	CbGeAlD
Theophylline—PDE5A—blood—acquired immunodeficiency syndrome	0.000801	0.00926	CbGeAlD
Theophylline—HDAC2—lymphoid tissue—acquired immunodeficiency syndrome	0.000797	0.00922	CbGeAlD
Theophylline—PDE3B—brain—acquired immunodeficiency syndrome	0.000792	0.00915	CbGeAlD
Theophylline—HDAC2—digestive system—acquired immunodeficiency syndrome	0.000787	0.0091	CbGeAlD
Theophylline—ADA—nervous system—acquired immunodeficiency syndrome	0.000785	0.00907	CbGeAlD
Theophylline—PDE3A—blood—acquired immunodeficiency syndrome	0.000779	0.00901	CbGeAlD
Theophylline—PDE3B—lymph node—acquired immunodeficiency syndrome	0.000765	0.00884	CbGeAlD
Theophylline—ADA—central nervous system—acquired immunodeficiency syndrome	0.000756	0.00874	CbGeAlD
Theophylline—PDE4C—brain—acquired immunodeficiency syndrome	0.00075	0.00868	CbGeAlD
Theophylline—HDAC2—blood—acquired immunodeficiency syndrome	0.00075	0.00867	CbGeAlD
Theophylline—PDE5A—vagina—acquired immunodeficiency syndrome	0.000743	0.00859	CbGeAlD
Theophylline—ADORA1—spinal cord—acquired immunodeficiency syndrome	0.000732	0.00846	CbGeAlD
Theophylline—HDAC2—bone marrow—acquired immunodeficiency syndrome	0.000726	0.00839	CbGeAlD
Theophylline—ADORA2A—nervous system—acquired immunodeficiency syndrome	0.000714	0.00826	CbGeAlD
Theophylline—ADORA1—vagina—acquired immunodeficiency syndrome	0.000704	0.00814	CbGeAlD
Theophylline—PDE5A—lung—acquired immunodeficiency syndrome	0.000702	0.00812	CbGeAlD
Theophylline—HDAC2—vagina—acquired immunodeficiency syndrome	0.000695	0.00804	CbGeAlD
Theophylline—ADORA2A—central nervous system—acquired immunodeficiency syndrome	0.000688	0.00795	CbGeAlD
Theophylline—PDE3A—lung—acquired immunodeficiency syndrome	0.000683	0.0079	CbGeAlD
Theophylline—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000682	0.00788	CbGeAlD
Theophylline—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000671	0.00776	CbGeAlD
Theophylline—ADORA1—lung—acquired immunodeficiency syndrome	0.000666	0.0077	CbGeAlD
Theophylline—PDE4D—brain—acquired immunodeficiency syndrome	0.000661	0.00764	CbGeAlD
Theophylline—HDAC2—lung—acquired immunodeficiency syndrome	0.000658	0.0076	CbGeAlD
Theophylline—ADORA2B—brain—acquired immunodeficiency syndrome	0.000656	0.00758	CbGeAlD
Theophylline—PDE5A—nervous system—acquired immunodeficiency syndrome	0.00065	0.00752	CbGeAlD
Theophylline—PDE4D—lymph node—acquired immunodeficiency syndrome	0.000638	0.00738	CbGeAlD
Theophylline—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000632	0.00731	CbGeAlD
Theophylline—PDE5A—central nervous system—acquired immunodeficiency syndrome	0.000626	0.00724	CbGeAlD
Theophylline—ADORA1—nervous system—acquired immunodeficiency syndrome	0.000617	0.00713	CbGeAlD
Theophylline—HDAC2—nervous system—acquired immunodeficiency syndrome	0.000609	0.00704	CbGeAlD
Theophylline—ADA—brain—acquired immunodeficiency syndrome	0.0006	0.00694	CbGeAlD
Theophylline—PDE4B—lymphoid tissue—acquired immunodeficiency syndrome	0.000597	0.0069	CbGeAlD
Theophylline—ADORA1—central nervous system—acquired immunodeficiency syndrome	0.000594	0.00686	CbGeAlD
Theophylline—HDAC2—central nervous system—acquired immunodeficiency syndrome	0.000586	0.00678	CbGeAlD
Theophylline—PDE4A—brain—acquired immunodeficiency syndrome	0.000585	0.00676	CbGeAlD
Theophylline—ADA—lymph node—acquired immunodeficiency syndrome	0.00058	0.0067	CbGeAlD
Theophylline—PDE4A—lymph node—acquired immunodeficiency syndrome	0.000565	0.00653	CbGeAlD
Theophylline—PDE4B—blood—acquired immunodeficiency syndrome	0.000562	0.0065	CbGeAlD
Theophylline—ADORA2A—brain—acquired immunodeficiency syndrome	0.000546	0.00631	CbGeAlD
Theophylline—PDE4B—bone marrow—acquired immunodeficiency syndrome	0.000544	0.00628	CbGeAlD
Theophylline—PDE4B—spinal cord—acquired immunodeficiency syndrome	0.000541	0.00626	CbGeAlD
Theophylline—SLC22A7—brain—acquired immunodeficiency syndrome	0.000541	0.00625	CbGeAlD
Theophylline—PDE4B—vagina—acquired immunodeficiency syndrome	0.000521	0.00602	CbGeAlD
Theophylline—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000512	0.00592	CbGeAlD
Theophylline—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000505	0.00584	CbGeAlD
Theophylline—PDE5A—brain—acquired immunodeficiency syndrome	0.000497	0.00575	CbGeAlD
Theophylline—PDE4B—lung—acquired immunodeficiency syndrome	0.000492	0.00569	CbGeAlD
Theophylline—PDE3A—brain—acquired immunodeficiency syndrome	0.000484	0.00559	CbGeAlD
Theophylline—CYP1B1—blood—acquired immunodeficiency syndrome	0.000481	0.00557	CbGeAlD
Theophylline—PDE5A—lymph node—acquired immunodeficiency syndrome	0.00048	0.00555	CbGeAlD
Theophylline—ADORA1—brain—acquired immunodeficiency syndrome	0.000471	0.00545	CbGeAlD
Theophylline—PDE3A—lymph node—acquired immunodeficiency syndrome	0.000467	0.0054	CbGeAlD
Theophylline—HDAC2—brain—acquired immunodeficiency syndrome	0.000466	0.00538	CbGeAlD
Theophylline—PDE4B—nervous system—acquired immunodeficiency syndrome	0.000456	0.00527	CbGeAlD
Theophylline—ADORA1—lymph node—acquired immunodeficiency syndrome	0.000455	0.00526	CbGeAlD
Theophylline—HDAC2—lymph node—acquired immunodeficiency syndrome	0.00045	0.0052	CbGeAlD
Theophylline—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000447	0.00516	CbGeAlD
Theophylline—PDE4B—central nervous system—acquired immunodeficiency syndrome	0.000439	0.00508	CbGeAlD
Theophylline—CYP1B1—lung—acquired immunodeficiency syndrome	0.000422	0.00488	CbGeAlD
Theophylline—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000396	0.00237	CcSEcCtD
Theophylline—Tension—Efavirenz—acquired immunodeficiency syndrome	0.000395	0.00237	CcSEcCtD
Theophylline—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000391	0.00235	CcSEcCtD
Theophylline—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000391	0.00235	CcSEcCtD
Theophylline—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000391	0.00235	CcSEcCtD
Theophylline—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000391	0.00452	CbGeAlD
Theophylline—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000391	0.00234	CcSEcCtD
Theophylline—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.000391	0.00234	CcSEcCtD
Theophylline—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.00039	0.00234	CcSEcCtD
Theophylline—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000389	0.00233	CcSEcCtD
Theophylline—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.000388	0.00233	CcSEcCtD
Theophylline—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000387	0.00232	CcSEcCtD
Theophylline—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000384	0.0023	CcSEcCtD
Theophylline—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000383	0.0023	CcSEcCtD
Theophylline—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.000379	0.00227	CcSEcCtD
Theophylline—Tension—Delavirdine—acquired immunodeficiency syndrome	0.000378	0.00226	CcSEcCtD
Theophylline—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000377	0.00226	CcSEcCtD
Theophylline—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000376	0.00435	CbGeAlD
Theophylline—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000376	0.00226	CcSEcCtD
Theophylline—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000375	0.00225	CcSEcCtD
Theophylline—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000374	0.00224	CcSEcCtD
Theophylline—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000374	0.00224	CcSEcCtD
Theophylline—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000374	0.00224	CcSEcCtD
Theophylline—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000372	0.00223	CcSEcCtD
Theophylline—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.00037	0.00222	CcSEcCtD
Theophylline—CYP2C8—blood—acquired immunodeficiency syndrome	0.000369	0.00426	CbGeAlD
Theophylline—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000368	0.00221	CcSEcCtD
Theophylline—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000367	0.0022	CcSEcCtD
Theophylline—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000366	0.0022	CcSEcCtD
Theophylline—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000365	0.00219	CcSEcCtD
Theophylline—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000364	0.00218	CcSEcCtD
Theophylline—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000362	0.00419	CbGeAlD
Theophylline—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000361	0.00217	CcSEcCtD
Theophylline—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.00036	0.00216	CcSEcCtD
Theophylline—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000357	0.00413	CbGeAlD
Theophylline—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000356	0.00214	CcSEcCtD
Theophylline—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000355	0.00213	CcSEcCtD
Theophylline—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000354	0.00212	CcSEcCtD
Theophylline—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000354	0.00212	CcSEcCtD
Theophylline—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000352	0.00211	CcSEcCtD
Theophylline—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000352	0.00211	CcSEcCtD
Theophylline—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000352	0.00211	CcSEcCtD
Theophylline—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000351	0.00211	CcSEcCtD
Theophylline—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00035	0.0021	CcSEcCtD
Theophylline—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000349	0.00209	CcSEcCtD
Theophylline—PDE4B—brain—acquired immunodeficiency syndrome	0.000349	0.00403	CbGeAlD
Theophylline—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000348	0.00209	CcSEcCtD
Theophylline—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.00208	CcSEcCtD
Theophylline—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000347	0.00208	CcSEcCtD
Theophylline—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000346	0.00208	CcSEcCtD
Theophylline—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000346	0.00207	CcSEcCtD
Theophylline—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000345	0.00207	CcSEcCtD
Theophylline—CYP1A2—blood—acquired immunodeficiency syndrome	0.000345	0.00399	CbGeAlD
Theophylline—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000344	0.00398	CbGeAlD
Theophylline—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000342	0.00205	CcSEcCtD
Theophylline—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000342	0.00205	CcSEcCtD
Theophylline—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000342	0.00205	CcSEcCtD
Theophylline—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000342	0.00395	CbGeAlD
Theophylline—Shock—Indinavir—acquired immunodeficiency syndrome	0.000342	0.00205	CcSEcCtD
Theophylline—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000341	0.00205	CcSEcCtD
Theophylline—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000341	0.00205	CcSEcCtD
Theophylline—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000341	0.00204	CcSEcCtD
Theophylline—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000341	0.00204	CcSEcCtD
Theophylline—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000341	0.00204	CcSEcCtD
Theophylline—CYP1A1—blood—acquired immunodeficiency syndrome	0.00034	0.00394	CbGeAlD
Theophylline—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00034	0.00204	CcSEcCtD
Theophylline—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.00204	CcSEcCtD
Theophylline—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00034	0.00204	CcSEcCtD
Theophylline—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00034	0.00204	CcSEcCtD
Theophylline—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000339	0.00203	CcSEcCtD
Theophylline—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000338	0.00203	CcSEcCtD
Theophylline—PDE4B—lymph node—acquired immunodeficiency syndrome	0.000337	0.00389	CbGeAlD
Theophylline—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000336	0.00202	CcSEcCtD
Theophylline—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000335	0.00201	CcSEcCtD
Theophylline—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000335	0.00201	CcSEcCtD
Theophylline—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.002	CcSEcCtD
Theophylline—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.00199	CcSEcCtD
Theophylline—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000331	0.00199	CcSEcCtD
Theophylline—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.00033	0.00381	CbGeAlD
Theophylline—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000328	0.00197	CcSEcCtD
Theophylline—CYP2C9—blood—acquired immunodeficiency syndrome	0.000328	0.00379	CbGeAlD
Theophylline—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000327	0.00196	CcSEcCtD
Theophylline—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000326	0.00196	CcSEcCtD
Theophylline—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000326	0.00377	CbGeAlD
Theophylline—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000325	0.00195	CcSEcCtD
Theophylline—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000323	0.00194	CcSEcCtD
Theophylline—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000323	0.00193	CcSEcCtD
Theophylline—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000322	0.00193	CcSEcCtD
Theophylline—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000321	0.00192	CcSEcCtD
Theophylline—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000321	0.00192	CcSEcCtD
Theophylline—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00032	0.00192	CcSEcCtD
Theophylline—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000318	0.0019	CcSEcCtD
Theophylline—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000317	0.0019	CcSEcCtD
Theophylline—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000317	0.0019	CcSEcCtD
Theophylline—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000316	0.00365	CbGeAlD
Theophylline—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000315	0.00189	CcSEcCtD
Theophylline—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000315	0.00189	CcSEcCtD
Theophylline—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000315	0.00189	CcSEcCtD
Theophylline—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.00189	CcSEcCtD
Theophylline—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000314	0.00188	CcSEcCtD
Theophylline—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000313	0.00188	CcSEcCtD
Theophylline—Rash—Didanosine—acquired immunodeficiency syndrome	0.000312	0.00187	CcSEcCtD
Theophylline—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000312	0.00187	CcSEcCtD
Theophylline—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000312	0.00187	CcSEcCtD
Theophylline—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000312	0.00187	CcSEcCtD
Theophylline—CYP2E1—blood—acquired immunodeficiency syndrome	0.00031	0.00359	CbGeAlD
Theophylline—Headache—Didanosine—acquired immunodeficiency syndrome	0.00031	0.00186	CcSEcCtD
Theophylline—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000309	0.00185	CcSEcCtD
Theophylline—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.00185	CcSEcCtD
Theophylline—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.00184	CcSEcCtD
Theophylline—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.00184	CcSEcCtD
Theophylline—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000305	0.00183	CcSEcCtD
Theophylline—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000305	0.00183	CcSEcCtD
Theophylline—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000305	0.00183	CcSEcCtD
Theophylline—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000304	0.00182	CcSEcCtD
Theophylline—CYP1A2—lung—acquired immunodeficiency syndrome	0.000302	0.0035	CbGeAlD
Theophylline—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000302	0.00181	CcSEcCtD
Theophylline—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000302	0.00181	CcSEcCtD
Theophylline—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.0003	0.0018	CcSEcCtD
Theophylline—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000299	0.0018	CcSEcCtD
Theophylline—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000299	0.00346	CbGeAlD
Theophylline—CYP1B1—brain—acquired immunodeficiency syndrome	0.000299	0.00345	CbGeAlD
Theophylline—CYP1A1—lung—acquired immunodeficiency syndrome	0.000298	0.00345	CbGeAlD
Theophylline—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000297	0.00178	CcSEcCtD
Theophylline—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000297	0.00178	CcSEcCtD
Theophylline—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000297	0.00178	CcSEcCtD
Theophylline—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000295	0.00177	CcSEcCtD
Theophylline—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000295	0.00177	CcSEcCtD
Theophylline—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000295	0.00177	CcSEcCtD
Theophylline—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000294	0.00176	CcSEcCtD
Theophylline—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000294	0.00176	CcSEcCtD
Theophylline—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000293	0.00176	CcSEcCtD
Theophylline—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000291	0.00174	CcSEcCtD
Theophylline—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00029	0.00174	CcSEcCtD
Theophylline—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000289	0.00334	CbGeAlD
Theophylline—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.00171	CcSEcCtD
Theophylline—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.00171	CcSEcCtD
Theophylline—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000285	0.00171	CcSEcCtD
Theophylline—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000285	0.00171	CcSEcCtD
Theophylline—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000284	0.0017	CcSEcCtD
Theophylline—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000284	0.0017	CcSEcCtD
Theophylline—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000284	0.0017	CcSEcCtD
Theophylline—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.0017	CcSEcCtD
Theophylline—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.0017	CcSEcCtD
Theophylline—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000283	0.0017	CcSEcCtD
Theophylline—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000281	0.00168	CcSEcCtD
Theophylline—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00028	0.00168	CcSEcCtD
Theophylline—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00028	0.00168	CcSEcCtD
Theophylline—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000279	0.00167	CcSEcCtD
Theophylline—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.00167	CcSEcCtD
Theophylline—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000277	0.00166	CcSEcCtD
Theophylline—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000277	0.00166	CcSEcCtD
Theophylline—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000276	0.00319	CbGeAlD
Theophylline—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000276	0.00165	CcSEcCtD
Theophylline—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.00165	CcSEcCtD
Theophylline—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000275	0.00165	CcSEcCtD
Theophylline—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000275	0.00165	CcSEcCtD
Theophylline—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000274	0.00164	CcSEcCtD
Theophylline—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000274	0.00164	CcSEcCtD
Theophylline—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000273	0.00164	CcSEcCtD
Theophylline—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.00164	CcSEcCtD
Theophylline—CYP2E1—lung—acquired immunodeficiency syndrome	0.000272	0.00315	CbGeAlD
Theophylline—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000272	0.00163	CcSEcCtD
Theophylline—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000272	0.00163	CcSEcCtD
Theophylline—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.00163	CcSEcCtD
Theophylline—Rash—Stavudine—acquired immunodeficiency syndrome	0.000271	0.00162	CcSEcCtD
Theophylline—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000271	0.00162	CcSEcCtD
Theophylline—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00027	0.00162	CcSEcCtD
Theophylline—Headache—Stavudine—acquired immunodeficiency syndrome	0.000269	0.00161	CcSEcCtD
Theophylline—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000269	0.00161	CcSEcCtD
Theophylline—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000268	0.00161	CcSEcCtD
Theophylline—Rash—Abacavir—acquired immunodeficiency syndrome	0.000267	0.0016	CcSEcCtD
Theophylline—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000267	0.0016	CcSEcCtD
Theophylline—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.0016	CcSEcCtD
Theophylline—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000266	0.0016	CcSEcCtD
Theophylline—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000266	0.00308	CbGeAlD
Theophylline—Headache—Abacavir—acquired immunodeficiency syndrome	0.000265	0.00159	CcSEcCtD
Theophylline—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00159	CcSEcCtD
Theophylline—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000264	0.00159	CcSEcCtD
Theophylline—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000264	0.00158	CcSEcCtD
Theophylline—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000263	0.00158	CcSEcCtD
Theophylline—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00157	CcSEcCtD
Theophylline—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000262	0.00303	CbGeAlD
Theophylline—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000261	0.00157	CcSEcCtD
Theophylline—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.00157	CcSEcCtD
Theophylline—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000261	0.00156	CcSEcCtD
Theophylline—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.00156	CcSEcCtD
Theophylline—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.00156	CcSEcCtD
Theophylline—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000258	0.00298	CbGeAlD
Theophylline—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000257	0.00154	CcSEcCtD
Theophylline—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000256	0.00154	CcSEcCtD
Theophylline—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00153	CcSEcCtD
Theophylline—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000256	0.00153	CcSEcCtD
Theophylline—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000255	0.00153	CcSEcCtD
Theophylline—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000254	0.00152	CcSEcCtD
Theophylline—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000253	0.00152	CcSEcCtD
Theophylline—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00151	CcSEcCtD
Theophylline—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000252	0.00291	CbGeAlD
Theophylline—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000251	0.00151	CcSEcCtD
Theophylline—CYP3A4—blood—acquired immunodeficiency syndrome	0.00025	0.00289	CbGeAlD
Theophylline—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.0015	CcSEcCtD
Theophylline—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.00149	CcSEcCtD
Theophylline—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.00149	CcSEcCtD
Theophylline—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.00149	CcSEcCtD
Theophylline—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000247	0.00148	CcSEcCtD
Theophylline—CYP2D6—blood—acquired immunodeficiency syndrome	0.000246	0.00284	CbGeAlD
Theophylline—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00147	CcSEcCtD
Theophylline—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00146	CcSEcCtD
Theophylline—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000243	0.0028	CbGeAlD
Theophylline—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00145	CcSEcCtD
Theophylline—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.00145	CcSEcCtD
Theophylline—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000238	0.00143	CcSEcCtD
Theophylline—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000237	0.00142	CcSEcCtD
Theophylline—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000237	0.00142	CcSEcCtD
Theophylline—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.00141	CcSEcCtD
Theophylline—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000235	0.00141	CcSEcCtD
Theophylline—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000234	0.0014	CcSEcCtD
Theophylline—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00139	CcSEcCtD
Theophylline—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.00139	CcSEcCtD
Theophylline—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.00139	CcSEcCtD
Theophylline—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.00138	CcSEcCtD
Theophylline—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00023	0.00138	CcSEcCtD
Theophylline—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00138	CcSEcCtD
Theophylline—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00138	CcSEcCtD
Theophylline—CYP2C8—brain—acquired immunodeficiency syndrome	0.000229	0.00265	CbGeAlD
Theophylline—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00137	CcSEcCtD
Theophylline—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.00135	CcSEcCtD
Theophylline—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00133	CcSEcCtD
Theophylline—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.00133	CcSEcCtD
Theophylline—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000222	0.00133	CcSEcCtD
Theophylline—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00132	CcSEcCtD
Theophylline—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00132	CcSEcCtD
Theophylline—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000221	0.00132	CcSEcCtD
Theophylline—Rash—Indinavir—acquired immunodeficiency syndrome	0.000219	0.00131	CcSEcCtD
Theophylline—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000219	0.00131	CcSEcCtD
Theophylline—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.00131	CcSEcCtD
Theophylline—Headache—Indinavir—acquired immunodeficiency syndrome	0.000218	0.0013	CcSEcCtD
Theophylline—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.0013	CcSEcCtD
Theophylline—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.00129	CcSEcCtD
Theophylline—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00128	CcSEcCtD
Theophylline—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.00127	CcSEcCtD
Theophylline—CYP1A1—brain—acquired immunodeficiency syndrome	0.000211	0.00244	CbGeAlD
Theophylline—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00126	CcSEcCtD
Theophylline—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00126	CcSEcCtD
Theophylline—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.00125	CcSEcCtD
Theophylline—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.00125	CcSEcCtD
Theophylline—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.00124	CcSEcCtD
Theophylline—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.00124	CcSEcCtD
Theophylline—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000206	0.00124	CcSEcCtD
Theophylline—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00123	CcSEcCtD
Theophylline—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.00123	CcSEcCtD
Theophylline—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00123	CcSEcCtD
Theophylline—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000204	0.00236	CbGeAlD
Theophylline—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000203	0.00234	CbGeAlD
Theophylline—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.0012	CcSEcCtD
Theophylline—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.0002	0.00231	CbGeAlD
Theophylline—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.00119	CcSEcCtD
Theophylline—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.00119	CcSEcCtD
Theophylline—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.00119	CcSEcCtD
Theophylline—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00119	CcSEcCtD
Theophylline—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.00118	CcSEcCtD
Theophylline—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.00118	CcSEcCtD
Theophylline—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000195	0.00226	CbGeAlD
Theophylline—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.00117	CcSEcCtD
Theophylline—CYP2E1—brain—acquired immunodeficiency syndrome	0.000193	0.00223	CbGeAlD
Theophylline—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000192	0.00222	CbGeAlD
Theophylline—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.00115	CcSEcCtD
Theophylline—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.00115	CcSEcCtD
Theophylline—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00113	CcSEcCtD
Theophylline—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.00112	CcSEcCtD
Theophylline—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.00111	CcSEcCtD
Theophylline—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.00111	CcSEcCtD
Theophylline—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.0011	CcSEcCtD
Theophylline—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.0011	CcSEcCtD
Theophylline—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.00109	CcSEcCtD
Theophylline—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.00109	CcSEcCtD
Theophylline—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.00107	CcSEcCtD
Theophylline—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.00106	CcSEcCtD
Theophylline—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.00106	CcSEcCtD
Theophylline—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.00106	CcSEcCtD
Theophylline—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.00105	CcSEcCtD
Theophylline—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.00103	CcSEcCtD
Theophylline—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.00102	CcSEcCtD
Theophylline—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.00101	CcSEcCtD
Theophylline—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.00101	CcSEcCtD
Theophylline—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.001	CcSEcCtD
Theophylline—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000996	CcSEcCtD
Theophylline—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.00095	CcSEcCtD
Theophylline—CYP2D6—brain—acquired immunodeficiency syndrome	0.000153	0.00176	CbGeAlD
Theophylline—CYP1B1—Metabolism—TAT—acquired immunodeficiency syndrome	5.4e-05	0.00145	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.34e-05	0.00143	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.34e-05	0.00143	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.32e-05	0.00143	CbGpPWpGaD
Theophylline—PDE4C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.32e-05	0.00143	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.28e-05	0.00142	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.26e-05	0.00141	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.2e-05	0.00139	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.2e-05	0.00139	CbGpPWpGaD
Theophylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	5.16e-05	0.00139	CbGpPWpGaD
Theophylline—ADORA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.16e-05	0.00138	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.09e-05	0.00136	CbGpPWpGaD
Theophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	5.04e-05	0.00135	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.03e-05	0.00135	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5e-05	0.00134	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5e-05	0.00134	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.94e-05	0.00133	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.94e-05	0.00133	CbGpPWpGaD
Theophylline—ADORA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.93e-05	0.00132	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.9e-05	0.00132	CbGpPWpGaD
Theophylline—PDE4C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.86e-05	0.0013	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—ALB—acquired immunodeficiency syndrome	4.85e-05	0.0013	CbGpPWpGaD
Theophylline—ADORA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.85e-05	0.0013	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.83e-05	0.0013	CbGpPWpGaD
Theophylline—PDE3B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.78e-05	0.00128	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.74e-05	0.00127	CbGpPWpGaD
Theophylline—PDE3B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.71e-05	0.00126	CbGpPWpGaD
Theophylline—PDE4D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.7e-05	0.00126	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.67e-05	0.00125	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.67e-05	0.00125	CbGpPWpGaD
Theophylline—PDE4D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.63e-05	0.00124	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.59e-05	0.00123	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.54e-05	0.00122	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.52e-05	0.00121	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.48e-05	0.0012	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.47e-05	0.0012	CbGpPWpGaD
Theophylline—PDE4A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.47e-05	0.0012	CbGpPWpGaD
Theophylline—ADORA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.44e-05	0.00119	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—ALB—acquired immunodeficiency syndrome	4.42e-05	0.00119	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.42e-05	0.00118	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.41e-05	0.00118	CbGpPWpGaD
Theophylline—PDE4A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.41e-05	0.00118	CbGpPWpGaD
Theophylline—PDE3A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.35e-05	0.00117	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.34e-05	0.00116	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.34e-05	0.00116	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.34e-05	0.00116	CbGpPWpGaD
Theophylline—PDE3B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.31e-05	0.00115	CbGpPWpGaD
Theophylline—PDE3A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.29e-05	0.00115	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.27e-05	0.00115	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.27e-05	0.00114	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.25e-05	0.00114	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.25e-05	0.00114	CbGpPWpGaD
Theophylline—ADORA1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	4.25e-05	0.00114	CbGpPWpGaD
Theophylline—PDE4D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.23e-05	0.00114	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.22e-05	0.00113	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.2e-05	0.00113	CbGpPWpGaD
Theophylline—ADORA1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.19e-05	0.00112	CbGpPWpGaD
Theophylline—PDE4B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.14e-05	0.00111	CbGpPWpGaD
Theophylline—ADORA1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.13e-05	0.00111	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.11e-05	0.0011	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.09e-05	0.0011	CbGpPWpGaD
Theophylline—PDE4B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.08e-05	0.00109	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.06e-05	0.00109	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.05e-05	0.00109	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.05e-05	0.00109	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.03e-05	0.00108	CbGpPWpGaD
Theophylline—PDE4A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.03e-05	0.00108	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4e-05	0.00107	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.96e-05	0.00106	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.95e-05	0.00106	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—IL2—acquired immunodeficiency syndrome	3.94e-05	0.00106	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.93e-05	0.00105	CbGpPWpGaD
Theophylline—PDE3A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.92e-05	0.00105	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.91e-05	0.00105	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.9e-05	0.00105	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.89e-05	0.00104	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.86e-05	0.00104	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.86e-05	0.00104	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.85e-05	0.00103	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.81e-05	0.00102	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.81e-05	0.00102	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.8e-05	0.00102	CbGpPWpGaD
Theophylline—ADORA1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.77e-05	0.00101	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.76e-05	0.00101	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.75e-05	0.00101	CbGpPWpGaD
Theophylline—PDE4B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.73e-05	0.001	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.71e-05	0.000995	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.7e-05	0.000993	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.7e-05	0.000991	CbGpPWpGaD
Theophylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	3.67e-05	0.000984	CbGpPWpGaD
Theophylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	3.67e-05	0.000984	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.66e-05	0.000982	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.61e-05	0.000968	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—IL2—acquired immunodeficiency syndrome	3.58e-05	0.000961	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.58e-05	0.000961	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.56e-05	0.000955	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—ALB—acquired immunodeficiency syndrome	3.53e-05	0.000948	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—TAT—acquired immunodeficiency syndrome	3.53e-05	0.000946	CbGpPWpGaD
Theophylline—HDAC2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.53e-05	0.000946	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.53e-05	0.000946	CbGpPWpGaD
Theophylline—HDAC2—Disease—CXCR4—acquired immunodeficiency syndrome	3.5e-05	0.00094	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.47e-05	0.000932	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.47e-05	0.000932	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.47e-05	0.000932	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.43e-05	0.000921	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.43e-05	0.000919	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.39e-05	0.000908	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.37e-05	0.000904	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.37e-05	0.000904	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.36e-05	0.0009	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—TAT—acquired immunodeficiency syndrome	3.33e-05	0.000892	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.31e-05	0.000889	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.31e-05	0.000889	CbGpPWpGaD
Theophylline—ADORA2A—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.28e-05	0.000879	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.26e-05	0.000875	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.23e-05	0.000868	CbGpPWpGaD
Theophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	3.21e-05	0.000862	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.19e-05	0.000855	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.15e-05	0.000846	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.15e-05	0.000846	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.14e-05	0.000843	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.1e-05	0.000833	CbGpPWpGaD
Theophylline—SLC22A7—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.1e-05	0.00083	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.07e-05	0.000823	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.07e-05	0.000823	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	3.05e-05	0.000818	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AGPS—acquired immunodeficiency syndrome	3e-05	0.000804	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.95e-05	0.000792	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.95e-05	0.000792	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.94e-05	0.000788	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.92e-05	0.000783	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.92e-05	0.000783	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.91e-05	0.000782	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.9e-05	0.000777	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.89e-05	0.000776	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.89e-05	0.000774	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—IL2—acquired immunodeficiency syndrome	2.87e-05	0.000769	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.85e-05	0.000765	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.83e-05	0.000758	CbGpPWpGaD
Theophylline—PDE4C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.81e-05	0.000754	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.68e-05	0.000719	CbGpPWpGaD
Theophylline—HDAC2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.66e-05	0.000713	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.65e-05	0.00071	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.64e-05	0.000709	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.61e-05	0.0007	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.61e-05	0.0007	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.6e-05	0.000698	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	2.59e-05	0.000695	CbGpPWpGaD
Theophylline—ADORA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.56e-05	0.000688	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.56e-05	0.000688	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.55e-05	0.000685	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.53e-05	0.000677	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.52e-05	0.000676	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	2.5e-05	0.000671	CbGpPWpGaD
Theophylline—PDE3B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.49e-05	0.000667	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.48e-05	0.000666	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	2.48e-05	0.000665	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.47e-05	0.000663	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.45e-05	0.000658	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.45e-05	0.000658	CbGpPWpGaD
Theophylline—PDE4D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.45e-05	0.000656	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.43e-05	0.000651	CbGpPWpGaD
Theophylline—HDAC2—Disease—CCR5—acquired immunodeficiency syndrome	2.4e-05	0.000644	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.4e-05	0.000644	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.38e-05	0.000639	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.36e-05	0.000634	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.33e-05	0.000626	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.33e-05	0.000625	CbGpPWpGaD
Theophylline—PDE4A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.33e-05	0.000625	CbGpPWpGaD
Theophylline—ADA—Metabolism—ALB—acquired immunodeficiency syndrome	2.32e-05	0.000622	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.31e-05	0.000619	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.3e-05	0.000617	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.28e-05	0.000612	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.28e-05	0.000612	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.27e-05	0.000609	CbGpPWpGaD
Theophylline—PDE3A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.27e-05	0.000608	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.26e-05	0.000606	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.25e-05	0.000603	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.22e-05	0.000596	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.22e-05	0.000596	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.21e-05	0.000594	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.19e-05	0.000587	CbGpPWpGaD
Theophylline—ADORA1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.18e-05	0.000585	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.16e-05	0.00058	CbGpPWpGaD
Theophylline—PDE4B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.15e-05	0.000578	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.13e-05	0.000571	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	2.12e-05	0.000569	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.11e-05	0.000567	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.11e-05	0.000567	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	2.11e-05	0.000566	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.1e-05	0.000564	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.06e-05	0.000552	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.02e-05	0.000543	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2e-05	0.000537	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.98e-05	0.000531	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.96e-05	0.000525	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.87e-05	0.000501	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.84e-05	0.000493	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.8e-05	0.000484	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.74e-05	0.000465	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.71e-05	0.000458	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.68e-05	0.000452	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.68e-05	0.000451	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.64e-05	0.000439	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.000419	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.53e-05	0.00041	CbGpPWpGaD
Theophylline—HDAC2—Disease—CD4—acquired immunodeficiency syndrome	1.51e-05	0.000404	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.51e-05	0.000404	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.5e-05	0.000402	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.39e-05	0.000373	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.38e-05	0.000369	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.37e-05	0.000367	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000358	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.33e-05	0.000356	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.31e-05	0.000352	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.31e-05	0.00035	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.3e-05	0.000349	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.25e-05	0.000335	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.24e-05	0.000333	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.22e-05	0.000326	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.21e-05	0.000324	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.19e-05	0.00032	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.17e-05	0.000314	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.16e-05	0.000312	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.16e-05	0.00031	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.15e-05	0.000308	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.72e-06	0.000261	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.71e-06	0.000261	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—ALB—acquired immunodeficiency syndrome	9.42e-06	0.000253	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.03e-06	0.000242	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.99e-06	0.000241	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.86e-06	0.000238	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.3e-06	0.000223	CbGpPWpGaD
Theophylline—HDAC2—Disease—IL6—acquired immunodeficiency syndrome	8.15e-06	0.000219	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.09e-06	0.000217	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.84e-06	0.00021	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.71e-06	0.000207	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.34e-06	0.000197	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.14e-06	0.000192	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.88e-06	0.000184	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.79e-06	0.000182	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	6.15e-06	0.000165	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	5.8e-06	0.000156	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.71e-06	0.000153	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	5.32e-06	0.000143	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.31e-06	0.000142	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.36e-06	0.000117	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	4.33e-06	0.000116	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.7e-06	9.92e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.85e-06	7.65e-05	CbGpPWpGaD
